Related Experiment Videos
Summary
This study found that 0.1% halcinonide topical cream was superior to a control corticosteroid for treating psoriasis. Halcinonide demonstrated better efficacy, with 80% of patients achieving good to excellent responses.
Area of Science:
- Dermatology
- Pharmacology
Background:
- Psoriasis is a chronic inflammatory skin condition.
- Topical corticosteroids are a common treatment for psoriasis.
Purpose of the Study:
- To compare the efficacy of 0.1% halcinonide topical cream against an active corticosteroid comparator for psoriasis treatment.
Main Methods:
- A double-blind, paired comparison study.
- 60 patients with psoriasis were treated with either 0.1% halcinonide or the control drug.
- Comparative responses and overall therapeutic responses were evaluated.
Main Results:
- 0.1% halcinonide demonstrated superiority over the control drug in a greater number of patients.
- Good to excellent therapeutic responses were observed in 80% of patients treated with halcinonide, versus 65% with the control drug.
Conclusions:
- 0.1% halcinonide topical cream is a more effective treatment for psoriasis compared to the tested active corticosteroid.
- Halcinonide offers a favorable therapeutic outcome for psoriasis patients.